<!DOCTYPE html><!-- This site was created in Webflow. https://webflow.com --><!-- Last Published: Sat Dec 21 2024 11:35:04 GMT+0000 (Coordinated Universal Time) --><html data-wf-domain="www.bio.xyz" data-wf-page="6347faaa7003db6a977507f8" data-wf-site="62873e140841d3b072b63035" lang="en" data-wf-collection="6347faaa7003db313d7507f6" data-wf-item-slug="biodaos-are-community-owned-research-translation-engines-not-investment-daos"><head><meta charset="utf-8"/><title>BioDAOs are Community-Owned Research Translation Engines • BIO Resources</title><meta content="Moving research from concept to market is like conducting a symphony - there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project." name="description"/><meta content="BioDAOs are Community-Owned Research Translation Engines • BIO Resources" property="og:title"/><meta content="Moving research from concept to market is like conducting a symphony - there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project." property="og:description"/><meta content="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/668f9438f23ebf4d8ed03d7c_Blog%20Post%20-%20bioDAOs%20comunity%20owned%20acceleration%20engines.jpg" property="og:image"/><meta content="BioDAOs are Community-Owned Research Translation Engines • BIO Resources" property="twitter:title"/><meta content="Moving research from concept to market is like conducting a symphony - there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project." property="twitter:description"/><meta content="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/668f9438f23ebf4d8ed03d7c_Blog%20Post%20-%20bioDAOs%20comunity%20owned%20acceleration%20engines.jpg" property="twitter:image"/><meta property="og:type" content="website"/><meta content="summary_large_image" name="twitter:card"/><meta content="width=device-width, initial-scale=1" name="viewport"/><meta content="Webflow" name="generator"/><link href="https://cdn.prod.website-files.com/62873e140841d3b072b63035/css/bio-xyz.webflow.a68822776.css" rel="stylesheet" type="text/css"/><script type="text/javascript">!function(o,c){var n=c.documentElement,t=" w-mod-";n.className+=t+"js",("ontouchstart"in o||o.DocumentTouch&&c instanceof DocumentTouch)&&(n.className+=t+"touch")}(window,document);</script><link href="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6650364f2b88c78adce95840_Favicon.png" rel="shortcut icon" type="image/x-icon"/><link href="https://cdn.prod.website-files.com/62873e140841d3b072b63035/665036a4cde8c7d99c14e1df_Webclip.png" rel="apple-touch-icon"/><!-- Finsweet Cookie Consent -->
<script async src="https://cdn.jsdelivr.net/npm/@finsweet/cookie-consent@1/fs-cc.js" fs-cc-mode="opt-in"></script>

<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-MJQQ2K9Q');</script>
<!-- End Google Tag Manager -->

<!-- Hotjar Tracking Code for https://bio.xyz/ -->
<script>
    (function(h,o,t,j,a,r){
        h.hj=h.hjfunction(){(h.hj.q=h.hj.q[]).push(arguments)};
        h._hjSettings={hjid:4997593,hjsv:6};
        a=o.getElementsByTagName('head')[0];
        r=o.createElement('script');r.async=1;
        r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
        a.appendChild(r);
    })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
</script></head><body class="body"><div class="page-wrapper"><div class="top-content"><div class="global-styles w-embed"><style>

/* Focus state style for keyboard navigation for the focusable elements */
*[tabindex]:focus-visible,
  input[type="file"]:focus-visible {
   outline: 0.125rem solid #4d65ff;
   outline-offset: 0.125rem;
}

/* Get rid of top margin on first element in any rich text element */
.w-richtext > :not(div):first-child, .w-richtext > div:first-child > :first-child {
  margin-top: 0 !important;
}

/* Get rid of bottom margin on last element in any rich text element */
.w-richtext>:last-child, .w-richtext ol li:last-child, .w-richtext ul li:last-child {
	margin-bottom: 0 !important;
}

/* Prevent all click and hover interaction with an element */
.pointer-events-off {
	pointer-events: none;
}

/* Enables all click and hover interaction with an element */
.pointer-events-on {
  pointer-events: auto;
}

/* Create a class of .div-square which maintains a 1:1 dimension of a div */
.div-square::after {
	content: "";
	display: block;
	padding-bottom: 100%;
}

/* Make sure containers never lose their center alignment */
.container-medium,.container-small, .container-large {
	margin-right: auto !important;
  margin-left: auto !important;
}

.w-input{ 
	color: #D7F9BF;
  text-decoration: none;
  font-size: inherit;
  }

/* 
Make the following elements inherit typography styles from the parent and not have hardcoded values. 
Important: You will not be able to style for example "All Links" in Designer with this CSS applied.
Uncomment this CSS to use it in the project. Leave this message for future hand-off.
*/
/*
a,
.w-input,
.w-select,
.w-tab-link,
.w-nav-link,
.w-dropdown-btn,
.w-dropdown-toggle,
.w-dropdown-link {
  color: inherit;
  text-decoration: inherit;
  font-size: inherit;
}
*/

/* Apply "..." after 3 lines of text */
.text-style-3lines {
	display: -webkit-box;
	overflow: hidden;
	-webkit-line-clamp: 3;
	-webkit-box-orient: vertical;
}

/* Apply "..." after 2 lines of text */
.text-style-2lines {
	display: -webkit-box;
	overflow: hidden;
	-webkit-line-clamp: 2;
	-webkit-box-orient: vertical;
}

/* Adds inline flex display */
.display-inlineflex {
  display: inline-flex;
}

/* These classes are never overwritten */
.hide {
  display: none !important;
}

@media screen and (max-width: 991px) {
    .hide, .hide-tablet {
        display: none !important;
    }
}
  @media screen and (max-width: 767px) {
    .hide-mobile-landscape{
      display: none !important;
    }
}
  @media screen and (max-width: 479px) {
    .hide-mobile{
      display: none !important;
    }
}
 
.margin-0 {
  margin: 0rem !important;
}
  
.padding-0 {
  padding: 0rem !important;
}

.spacing-clean {
padding: 0rem !important;
margin: 0rem !important;
}

.margin-top {
  margin-right: 0rem !important;
  margin-bottom: 0rem !important;
  margin-left: 0rem !important;
}

.padding-top {
  padding-right: 0rem !important;
  padding-bottom: 0rem !important;
  padding-left: 0rem !important;
}
  
.margin-right {
  margin-top: 0rem !important;
  margin-bottom: 0rem !important;
  margin-left: 0rem !important;
}

.padding-right {
  padding-top: 0rem !important;
  padding-bottom: 0rem !important;
  padding-left: 0rem !important;
}

.margin-bottom {
  margin-top: 0rem !important;
  margin-right: 0rem !important;
  margin-left: 0rem !important;
}

.padding-bottom {
  padding-top: 0rem !important;
  padding-right: 0rem !important;
  padding-left: 0rem !important;
}

.margin-left {
  margin-top: 0rem !important;
  margin-right: 0rem !important;
  margin-bottom: 0rem !important;
}
  
.padding-left {
  padding-top: 0rem !important;
  padding-right: 0rem !important;
  padding-bottom: 0rem !important;
}
  
.margin-horizontal {
  margin-top: 0rem !important;
  margin-bottom: 0rem !important;
}

.padding-horizontal {
  padding-top: 0rem !important;
  padding-bottom: 0rem !important;
}

.margin-vertical {
  margin-right: 0rem !important;
  margin-left: 0rem !important;
}
  
.padding-vertical {
  padding-right: 0rem !important;
  padding-left: 0rem !important;
}

/* Apply "..." at 100% width */
.truncate-width { 
		width: 100%; 
    white-space: nowrap; 
    overflow: hidden; 
    text-overflow: ellipsis; 
}
/* Removes native scrollbar */
.no-scrollbar {
    -ms-overflow-style: none;
    overflow: -moz-scrollbars-none; 
}

.no-scrollbar::-webkit-scrollbar {
    display: none;
}

</style></div><div class="cookie-consent"><div fs-cc="banner" class="fs-cc-banner_component"><div class="fs-cc-banner_container"><div class="fs-cc-banner_text">By clicking <strong>“Accept All Cookies”</strong>, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our <a href="#" class="fs-cc-banner_text-link">Privacy Policy</a> for more information.</div><div class="fs-cc-banner_buttons-wrapper"><a fs-cc="open-preferences" href="#" class="fs-cc-banner_text-link">Preferences</a><a fs-cc="deny" href="#" class="fs-cc-banner_button fs-cc-button-alt w-button">Deny</a><a fs-cc="allow" href="#" class="fs-cc-banner_button w-button">Accept</a></div></div><div fs-cc="interaction" class="fs-cc-banner_trigger"></div></div><div fs-cc-scroll="disable" fs-cc="preferences" class="fs-cc-prefs_component w-form"><form id="cookie-preferences" name="wf-form-Cookie-Preferences" data-name="Cookie Preferences" method="get" class="fs-cc-prefs_form" data-wf-page-id="6347faaa7003db6a977507f8" data-wf-element-id="8d849d8f-eb62-9cc5-b835-613594461422"><div fs-cc="close" class="fs-cc-prefs_close"><div class="fs-cc-prefs_close-icon w-embed"><svg fill="currentColor" aria-hidden="true" focusable="false" viewBox="0 0 16 24">
	<path d="M9.414 8l4.293-4.293-1.414-1.414L8 6.586 3.707 2.293 2.293 3.707 6.586 8l-4.293 4.293 1.414 1.414L8 9.414l4.293 4.293 1.414-1.414L9.414 8z"></path>
</svg></div></div><div class="fs-cc-prefs_content"><div class="fs-cc-prefs_space-small"><div class="fs-cc-prefs_title">Privacy Preference Center</div></div><div class="fs-cc-prefs_space-small"><div class="fs-cc-prefs_text">When you visit websites, they may store or retrieve data in your browser. This storage is often necessary for the basic functionality of the website. The storage may be used for marketing, analytics, and personalization of the site, such as storing your preferences. Privacy is important to us, so you have the option of disabling certain types of storage that may not be necessary for the basic functioning of the website. Blocking categories may impact your experience on the website.</div></div><div class="fs-cc-prefs_space-medium"><a fs-cc="deny" href="#" class="fs-cc-prefs_button fs-cc-button-alt w-button">Reject all cookies</a><a fs-cc="allow" href="#" class="fs-cc-prefs_button w-button">Allow all cookies</a></div><div class="fs-cc-prefs_space-small"><div class="fs-cc-prefs_title">Manage Consent Preferences by Category</div></div><div class="fs-cc-prefs_option"><div class="fs-cc-prefs_toggle-wrapper"><div class="fs-cc-prefs_label">Essential</div><div class="fs-cc-prefs_text"><strong>Always Active</strong></div></div><div class="fs-cc-prefs_text">These items are required to enable basic website functionality.</div></div><div class="fs-cc-prefs_option"><div class="fs-cc-prefs_toggle-wrapper"><div class="fs-cc-prefs_label">Marketing</div><label class="w-checkbox fs-cc-prefs_checkbox-field"><input type="checkbox" id="marketing-2" name="marketing-2" data-name="Marketing 2" fs-cc-checkbox="marketing" class="w-checkbox-input fs-cc-prefs_checkbox"/><span for="marketing-2" class="fs-cc-prefs_checkbox-label w-form-label">Essential</span><div class="fs-cc-prefs_toggle"></div></label></div><div class="fs-cc-prefs_text">These items are used to deliver advertising that is more relevant to you and your interests. They may also be used to limit the number of times you see an advertisement and measure the effectiveness of advertising campaigns. Advertising networks usually place them with the website operator’s permission.</div></div><div class="fs-cc-prefs_option"><div class="fs-cc-prefs_toggle-wrapper"><div class="fs-cc-prefs_label">Personalization</div><label class="w-checkbox fs-cc-prefs_checkbox-field"><input type="checkbox" id="personalization-2" name="personalization-2" data-name="Personalization 2" fs-cc-checkbox="personalization" class="w-checkbox-input fs-cc-prefs_checkbox"/><span for="personalization-2" class="fs-cc-prefs_checkbox-label w-form-label">Essential</span><div class="fs-cc-prefs_toggle"></div></label></div><div class="fs-cc-prefs_text">These items allow the website to remember choices you make (such as your user name, language, or the region you are in) and provide enhanced, more personal features. For example, a website may provide you with local weather reports or traffic news by storing data about your current location.</div></div><div class="fs-cc-prefs_option"><div class="fs-cc-prefs_toggle-wrapper"><div class="fs-cc-prefs_label">Analytics</div><label class="w-checkbox fs-cc-prefs_checkbox-field"><input type="checkbox" id="analytics-2" name="analytics-2" data-name="Analytics 2" fs-cc-checkbox="analytics" class="w-checkbox-input fs-cc-prefs_checkbox"/><span for="analytics-2" class="fs-cc-prefs_checkbox-label w-form-label">Essential</span><div class="fs-cc-prefs_toggle"></div></label></div><div class="fs-cc-prefs_text">These items help the website operator understand how its website performs, how visitors interact with the site, and whether there may be technical issues. This storage type usually doesn’t collect information that identifies a visitor.</div></div><div class="fs-cc-prefs_buttons-wrapper"><a fs-cc="submit" href="#" class="fs-cc-prefs_button w-button">Confirm my preferences and close</a></div><input type="submit" data-wait="Please wait..." class="fs-cc-prefs_submit-hide w-button" value="Submit"/><div class="w-embed"><style>
/* smooth scrolling on iOS devices */
.fs-cc-prefs_content{-webkit-overflow-scrolling: touch}
</style></div></div></form><div class="w-form-done"></div><div class="w-form-fail"></div><div fs-cc="close" class="fs-cc-prefs_overlay"></div><div fs-cc="interaction" class="fs-cc-prefs_trigger"></div></div></div></div><div data-animation="default" data-collapse="medium" data-duration="0" data-easing="linear" data-easing2="linear" role="banner" class="nav-24 w-nav light-mode"><div class="dynamic-notification-wrap w-dyn-list"><div role="list" class="dynamic-notification-list w-dyn-items"><div role="listitem" class="dynamic-notification-item w-dyn-item"><div class="notification-banner"><div class="notification-rich-text w-richtext"><p>Quantum Biology DAO raises $6.8M through BIO auction launchpad! <a href="https://auctions.bio.xyz/auction/560">Claim QBIO now</a></p></div></div></div></div></div><div class="nav-container"><div class="nav-inner"><a href="/" class="main-logo w-nav-brand light-mode"><div class="nav-logo-embed w-embed"><svg width="140" height="40" viewBox="0 0 140 40" fill="currentColor" xmlns="http://www.w3.org/2000/svg">
<path fill-rule="evenodd" clip-rule="evenodd" d="M63.8372 0H121.429C131.165 0 139.059 7.89169 139.059 17.6281V22.3701C139.059 32.1044 131.165 39.9981 121.429 39.9981H63.8372C54.1029 39.9981 46.2092 32.1064 46.2092 22.3701V17.6281C46.2092 7.89375 54.1009 0 63.8372 0ZM63.431 33.5387H75.3649L75.367 33.5366C79.7089 33.5366 83.4557 30.1571 83.5583 25.8152C83.6034 23.8803 82.9529 22.0992 81.8387 20.7039C81.2909 20.0165 81.2457 19.0644 81.6787 18.299C82.4584 16.9202 82.838 15.2868 82.6534 13.5509C82.2204 9.49014 78.607 6.50665 74.5236 6.50665H63.431C57.4845 6.50665 52.6666 11.3266 52.6666 17.271V22.7743C52.6666 28.7187 57.4865 33.5387 63.431 33.5387ZM92.6339 33.4894C94.0764 33.4894 95.246 32.3198 95.246 30.8773V9.0736C95.246 7.6311 94.0785 6.4615 92.6339 6.4615C91.1893 6.4615 90.0198 7.6311 90.0198 9.0736V30.8773C90.0198 32.3198 91.1914 33.4894 92.6339 33.4894ZM120.963 33.5387C127.387 33.5387 132.597 28.3309 132.597 21.9043V18.1431C132.597 11.7185 127.389 6.5087 120.963 6.5087H113.342C106.917 6.5087 101.708 11.7165 101.708 18.1431V21.9043C101.708 28.3288 106.915 33.5387 113.342 33.5387H120.963ZM1.32133 38.693C0.863753 38.2149 0.512874 37.6486 0.287163 37.0269C0.0614513 36.4051 -0.0329371 35.7444 0.0101533 35.0858C0.0532436 34.4271 0.233813 33.7828 0.539549 33.198C0.845285 32.6111 1.26798 32.0961 1.78301 31.6837C3.00956 30.7983 3.98234 30.5973 4.99694 30.3876C5.2333 30.3388 5.47192 30.2894 5.71655 30.2309C7.91621 29.6995 9.80808 28.0394 9.46541 25.6059C9.169 23.5095 7.65363 22.9593 6.28168 22.4612C5.0418 22.011 3.91906 21.6034 3.91906 20.1354C3.91906 18.6668 5.04105 18.2595 6.28058 17.8095C7.65088 17.312 9.16482 16.7624 9.46541 14.6691C9.80808 12.254 7.91621 10.5899 5.71655 10.0441C5.47499 9.98628 5.2393 9.93733 5.00589 9.88886C3.98819 9.67751 3.0139 9.47518 1.78712 8.58722C1.27209 8.17479 0.847337 7.6577 0.541601 7.0729C0.235865 6.484 0.0552955 5.84175 0.0122052 5.18103C-0.0308852 4.52236 0.0635032 3.85959 0.289215 3.23786C0.514926 2.61613 0.867857 2.0498 1.32544 1.5717C1.80353 1.11412 2.36986 0.761189 2.98954 0.535477C3.60922 0.309766 4.27199 0.215377 4.93066 0.258468C5.58933 0.301558 6.23158 0.482127 6.81843 0.787864C7.40323 1.0936 7.92031 1.51835 8.33275 2.03338C9.2203 3.26294 9.42284 4.23884 9.63409 5.25666C9.68266 5.49068 9.73169 5.72692 9.78961 5.96897C10.3211 8.17068 11.9811 10.0626 14.4126 9.71988C16.5056 9.42349 17.0555 7.90713 17.5533 6.53417C18.0033 5.29323 18.4108 4.16943 19.8769 4.16943C21.3428 4.16943 21.7503 5.2916 22.2007 6.53158C22.6991 7.90377 23.2498 9.42023 25.3452 9.71988C27.7583 10.0626 29.4183 8.17068 29.9682 5.96897C30.0269 5.72361 30.0764 5.48423 30.1253 5.24707C30.3348 4.23271 30.5358 3.25908 31.4189 2.03338C31.8314 1.51835 32.3484 1.0936 32.9332 0.787864C33.518 0.482127 34.1623 0.301558 34.821 0.258468C35.4797 0.215377 36.1404 0.309766 36.7621 0.535477C37.3818 0.761189 37.9502 1.11412 38.4262 1.5717C38.8838 2.04774 39.2367 2.61613 39.4625 3.23786C39.6882 3.85959 39.7825 4.52031 39.7395 5.18103C39.6964 5.8397 39.5158 6.484 39.2101 7.07085C38.9043 7.6577 38.4796 8.17273 37.9646 8.58517C36.7355 9.47236 35.7612 9.6751 34.7466 9.88625C34.5128 9.9349 34.2768 9.98401 34.0351 10.042C31.8293 10.5694 29.9395 12.2335 30.2822 14.6671C30.5784 16.7605 32.0927 17.3095 33.4643 17.8067C34.7048 18.2564 35.8285 18.6638 35.8285 20.1334C35.8285 21.6027 34.7061 22.0102 33.4663 22.4603C32.0952 22.9581 30.5806 23.5079 30.2822 25.6038C29.9395 28.0189 31.8314 29.6789 34.0351 30.2063C34.2834 30.2668 34.5258 30.3175 34.7661 30.3678C35.7729 30.5786 36.7437 30.7819 37.9646 31.6631C38.4796 32.0756 38.9043 32.5927 39.2101 33.1775C39.5158 33.7643 39.6964 34.4066 39.7395 35.0673C39.7825 35.7259 39.6882 36.3887 39.4625 37.0105C39.2367 37.6322 38.8838 38.1985 38.4262 38.6766C37.9502 39.1342 37.3818 39.4871 36.7621 39.7128C36.1404 39.9385 35.4797 40.0329 34.821 39.9898C34.1623 39.9468 33.518 39.7662 32.9332 39.4605C32.3484 39.1547 31.8314 38.73 31.4189 38.2129C30.535 36.9883 30.3345 36.0154 30.1257 35.0021C30.0767 34.764 30.0272 34.5236 29.9682 34.2773C29.4368 32.0756 27.7768 30.1837 25.3452 30.5264C23.2501 30.8228 22.7004 32.339 22.2025 33.7119C21.7525 34.9529 21.345 36.0768 19.8769 36.0768C18.4081 36.0768 18.0008 34.9533 17.551 33.7124C17.0539 32.3408 16.5047 30.8259 14.4126 30.5264C11.9995 30.1837 10.3395 32.0756 9.78961 34.2814C9.73151 34.5234 9.68236 34.7597 9.63365 34.9939C9.42256 36.0088 9.21968 36.9842 8.33275 38.2129C7.92031 38.73 7.40528 39.1547 6.81843 39.4605C6.23363 39.7662 5.58933 39.9468 4.93066 39.9898C4.27199 40.0329 3.61128 39.9385 2.98954 39.7128C2.36781 39.4871 1.80148 39.1342 1.32544 38.6766L1.32133 38.693ZM75.525 22.331H74.7924H74.7883H59.6267C58.7054 22.331 57.9585 23.0779 57.9585 23.9992C57.9585 26.72 60.1643 28.9259 62.8851 28.9259H75.6501C77.6836 28.9259 79.2882 27.0832 78.884 24.9759C78.5844 23.4103 77.1214 22.331 75.527 22.331H75.525ZM74.7883 17.7162H59.6246V17.7182C58.7033 17.7182 57.9564 16.9713 57.9564 16.05C57.9564 13.3292 60.1622 11.1234 62.883 11.1234H74.6016C76.3867 11.1234 77.9852 12.4592 78.0796 14.2423C78.1801 16.1424 76.6679 17.7162 74.7883 17.7162ZM121.837 11.1234H112.464C109.443 11.1234 106.995 13.5716 106.995 16.5917V23.4575C106.995 26.4776 109.443 28.9258 112.464 28.9258H121.837C124.857 28.9258 127.305 26.4776 127.305 23.4575V16.5917C127.305 13.5716 124.857 11.1234 121.837 11.1234Z" fill="currentColor"/>
</svg></div></a><nav role="navigation" class="main-menu-container w-nav-menu"><div class="mobile-top-links"><a href="/bio-token" class="nav-link-24 light-mode">BIO Token</a><a href="/scientists" target="_blank" class="nav-link-24 light-mode">Scientists</a><a href="https://form.typeform.com/to/K8bnPElt" target="_blank" class="nav-link-24 light-mode">Careers</a><a href="/blog" class="nav-link-24 light-mode">Blog</a><a href="https://docs.bio.xyz/bio" target="_blank" class="nav-link-24 light-mode">Docs</a></div><div class="nav-right"><a href="http://t.me/bio_protocol" target="_blank" class="nav-link-24 light-mode">Telegram</a><a href="https://x.com/bioprotocol" target="_blank" class="nav-link-24 light-mode">X</a><a href="https://discord.com/invite/YnwhX6GzWH" target="_blank" class="nav-link-24 light-mode">Discord</a><div class="nav-bar-btns"><a href="https://app.bio.xyz/launchpad" target="_blank" class="button nav w-button">Launch App</a></div></div></nav><div class="menu-btn-2 w-nav-button"><div class="burger-container"><div class="burger-linetop light-mode"></div><div class="burger-lline-middle light-mode"></div><div class="burger-line-bottom light-mode"></div></div></div></div></div></div><div class="main-wrapper"><div class="section-new top"><div class="container-blog-body"><div class="article-head"><img src="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/668f9438f23ebf4d8ed03d7c_Blog%20Post%20-%20bioDAOs%20comunity%20owned%20acceleration%20engines.jpg" loading="lazy" width="Auto" alt="" sizes="(max-width: 479px) 94vw, (max-width: 767px) 93vw, (max-width: 991px) 90vw, 752px" srcset="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/668f9438f23ebf4d8ed03d7c_Blog%20Post%20-%20bioDAOs%20comunity%20owned%20acceleration%20engines-p-500.jpg 500w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/668f9438f23ebf4d8ed03d7c_Blog%20Post%20-%20bioDAOs%20comunity%20owned%20acceleration%20engines-p-800.jpg 800w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/668f9438f23ebf4d8ed03d7c_Blog%20Post%20-%20bioDAOs%20comunity%20owned%20acceleration%20engines-p-1080.jpg 1080w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/668f9438f23ebf4d8ed03d7c_Blog%20Post%20-%20bioDAOs%20comunity%20owned%20acceleration%20engines.jpg 1600w" class="blog-header-image"/><div class="spacer-medium"></div><div class="article-date-auth"><div class="blog-credits">Mar 18, 2023</div><div class="blog-tag-text bullet"> • </div><div class="blog-credits">Tyler Golato, Paul Kohlhaas, Jesse Hudson, Vincent Weisser, Benji Leibowitz</div></div><div class="spacer-small"></div><h1 class="heading-style-h2">BioDAOs are Community-Owned Research Translation Engines</h1><div class="spacer-medium"></div></div><div class="blog-tags-and-share"><div class="blog-tags"><div class="collection-list-wrapper-2 w-dyn-list"><div role="list" class="collection-list w-dyn-items"><div role="listitem" class="blog-tag-item w-dyn-item"><div class="blog-tag-text">BioDAOs</div></div><div role="listitem" class="blog-tag-item w-dyn-item"><div class="blog-tag-text">DeSci</div></div></div></div></div><div class="blog-social-links"><div class="filter blog-inner">Share This</div><div class="social-hidden"><a href="#" class="_w-inline-block blog-social-link twitter w-inline-block"><img src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6323026f92a78e460ba0ad45_twitter.svg" loading="lazy" alt="" class="blog-social-img"/></a><a href="#" class="_w-inline-block blog-social-link facebook w-inline-block"><img src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6348101770281e9027754b63_fb-green.svg" loading="lazy" alt="" class="blog-social-img"/></a><a href="#" class="_w-inline-block blog-social-link linked w-inline-block"><img src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6323026fa0941a747b45eaf9_linkedin.svg" loading="lazy" alt="" class="blog-social-img"/></a></div><div class="html-embed w-embed"><a class="w-inline-block blog-social-link twitter" href="https://twitter.com/intent/tweet?" target="_blank" title="Tweet" onclick="window.open('https://twitter.com/intent/tweet?text=%20Check%20up%20this%20awesome%20content' + encodeURIComponent(document.title) + ':%20 ' + encodeURIComponent(document.URL)); return false;"><img alt=“twitter-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/668fcd45359aba9eb2704a86_664735ffce358da0095d6142_x.svg" width=16" height=auto" ></a></div><div class="html-embed w-embed"><a class="w-inline-block blog-social-link facebook" href="https://www.facebook.com/sharer/sharer.php?u=&t=" title="Share on Facebook" target="_blank" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=' + encodeURIComponent(document.URL) + '&t=' + encodeURIComponent(document.URL)); return false;"><img alt=“facebook-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6348101770281e9027754b63_fb-green.svg" width=16" height=auto" margin-left=12px"></a></div><div class="code-embed-3 w-embed"><a class="w-inline-block blog-social-link linked" href="http://www.linkedin.com/shareArticle?mini=true&url=&title=&summary=&source=" target="_blank" title="Share on LinkedIn" onclick="window.open('http://www.linkedin.com/shareArticle?mini=true&url=' + encodeURIComponent(document.URL) + '&title=' + encodeURIComponent(document.title)); return false;"><img alt="linkedin-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6323026fa0941a747b45eaf9_linkedin.svg" width="16" height=auto"></a></div><div class="code-embed w-embed w-script"><style><a class="w-inline-block blog-social-link twitter" href="https://twitter.com/intent/tweet?" target="_blank" title="Tweet" onclick="window.open('https://twitter.com/intent/tweet?text=%20Check%20up%20this%20awesome%20content' + encodeURIComponent(document.title) + ':%20 ' + encodeURIComponent(document.URL)); return false;"><img alt=“twitter-icon" src="https://cdn.prod.website-files.com/5fcf058ca5a742c36f247ef0/624599b9beac3569237f4d45_twitter-blog.svg" width=16" height=auto"></a>



<a class="w-inline-block blog-social-link fb" href="https://www.facebook.com/sharer/sharer.php?u=&t=" title="Share on Facebook" target="_blank" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=' + encodeURIComponent(document.URL) + '&t=' + encodeURIComponent(document.URL)); return false;"><img alt=“facebook-icon" src="https://cdn.prod.website-files.com/5fcf058ca5a742c36f247ef0/624599b9c3e7fb0b56a00b6d_fb-blog.svg" width=16" height=auto"> </a>



<a class="w-inline-block blog-social-link linked" href="http://www.linkedin.com/shareArticle?mini=true&url=&title=&summary=&source=" target="_blank" title="Share on LinkedIn" onclick="window.open('http://www.linkedin.com/shareArticle?mini=true&url=' + encodeURIComponent(document.URL) + '&title=' + encodeURIComponent(document.title)); return false;"><img alt=“linkedin-icon" src="https://cdn.prod.website-files.com/5fcf058ca5a742c36f247ef0/624599b9878fd25a93c4342c_linkedin-blog.svg" width=16" height=auto"></a>

</style>




<!DOCTYPE html>
<html>
<body>
<style>
button{
background-color:#ffffff;
</style>
<button  onclick="copyToClipboard()" style="background-color:#ffffff;" ><img alt=“link-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/63481017df196e8327d2ffa8_link-green.svg" width=16" height=auto"></button>

<script>
function copyToClipboard(text) {
var inputc = document.body.appendChild(document.createElement("input"));
inputc.value = window.location.href;
inputc.focus();
inputc.select();
document.execCommand('copy');
inputc.parentNode.removeChild(inputc);
alert("URL Copied.");
}
</script>

</body>
</html></div></div></div><div class="spacer-medium"></div><div class="line"></div><div class="spacer-medium"></div><div class="rich-text-blog w-richtext"><p>Moving research from concept to market is like conducting a symphony - there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project. As research continues to speed up and span across disciplines, the challenge of bringing new ideas and innovations from the academic sphere to the commercial realm becomes increasingly crucial. For instance, many of the top-selling therapeutics available today were originally developed in academia and had to navigate the difficult path of translation.</p><p>‍</p><p>The process of transforming a therapeutic or technology from the research and development stage into a market-ready product or service is intricate and laden with obstacles. Presently, it calls for the cooperation and coordination of a multitude of organizations, along with funding, expertise, collaboration, and various other resources and support. BioDAOs streamline the process by consolidating all pertinent stakeholders into a single, internet-based virtual organization. This vertical integration enables a seamless end-to-end approach, fostering increased efficiency, collaboration, and resource-sharing throughout the entire research and development journey.</p><p>‍</p><p>In this brief piece, we delve into the challenges and opportunities associated with translating research from academic institutions and investigate how organizations like BioDAOs are contributing to the support and facilitation of this vital process. </p><h2>The Primitives of Biomedical Discovery and Development</h2><p>It&#x27;s noteworthy that the majority of approved medicines, around 60%, have their roots in academia, <a href="https://www.cbo.gov/publication/57126">with the remaining 40% stemming from pharmaceutical research and discovery</a>. Early-stage therapeutic research generally involves target-based or phenotypic screening using cell lines (in vitro) and model organisms (in vivo), <a href="https://www.plengegen.com/wp-content/uploads/Swinney_ClinPharmTher_2013_phenotypic-screens.pdf">depending on the disease model being studied</a>. This work is often <a href="https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-9-S1-S2">grant-funded and carried out in academic labs</a> until patents or other intellectual property (IP) are filed by the university&#x27;s technology transfer office (TTO).</p><p>‍</p><p>The university then licenses the IP to an existing pharmaceutical company or a biotech startup, which takes on Investigational New Drug (IND) enabling studies. These studies involve more in vivo testing in increasingly larger animals to evaluate safety and efficacy. This phase is typically executed by private biotech labs and/or contract research organizations, funded by venture capital and/or pharma balance sheets. Clinical development kicks off when the company files an <a href="https://www.fda.gov/drugs/information-consumers-and-patients-drugs/fdas-drug-review-process-ensuring-drugs-are-safe-and-effective">IND with the FDA</a>, progressing through Phase I for safety, Phase II for early signs of efficacy, and Phase III for determining full approval.</p><p>‍</p><p>Once an experimental medicine has undergone all clinical development phases, the company files a new drug application (<a href="https://www.fda.gov/drugs/types-applications/new-drug-application-nda">NDA</a> - or <a href="https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/obtaining-eu-marketing-authorisation-step-step">MAA</a>), which can be approved or denied by the FDA (or EMA). If approved, the company can then market and distribute the therapeutic. This process entails a blend of patient- and physician-targeted marketing to ensure the maximum number of eligible patients receive the treatment.</p><p>‍</p><p>Throughout this progression, the therapeutic IP is often transferred among multiple organizations, including academia, biotech, and pharma. Funding typically comes from a <a href="https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-9-S1-S2">mix of government agencies, venture capitalists (VCs), and pharmaceutical companies</a>. The goal of a BioDAO is to consolidate all funding and development functions for a specific therapeutic area within a single organization, streamlining the entire process.</p><h2>What is a BioDAO?</h2><p>A <a href="https://www.molecule.to/blog/the-emergence-of-biotech-daos">BioDAO</a> refers to a decentralized autonomous organization (DAO) that specializes in harnessing the collective efforts of a diverse group of stakeholders to expedite the development and distribution of biotechnology products and services, spanning from early concept to market. BioDAOs fund and incubate projects during the initial stages of translational research, often through IP-NFTs, <a href="https://medium.com/molecule-blog/ip-nfts-for-researchers-a-new-biomedical-funding-paradigm-91312d8d92e6">even before a company is established</a>. While venture studios and corporate venture arms share similarities, BioDAOs stand out as community-owned and operated entities.</p><p>Contrasting with venture studios and corporate venture arms, where investment is the primary activity and profits are distributed to shareholders or partners, investment in BioDAOs is a secondary endeavor within the community, akin to venture investments by a university endowment supporting the university&#x27;s operations. Returns from BioDAO investments are channeled into funding further research and operations, mirroring how a university endowment&#x27;s investments contribute to additional research, facility improvements, and the university&#x27;s functioning. However, BioDAOs differ from universities in their ability to vertically integrate the scientific discovery and commercial development of biotechnology products and services for a specific indication or therapeutic area, unifying all relevant stakeholders within a single, internet-based virtual organization.</p><p>‍</p><p>During a project&#x27;s early stages, BioDAOs engage in activities such as inventing novel IP, funding and developing research from its members and consolidating biomedical datasets among their members. As projects advance and gain value within the community, BioDAOs allocate more resources toward company formation, business development, scaling, regulatory filing, and distribution of biotechnology products. By fostering a community of stakeholders with aligned incentives and diverse backgrounds, BioDAOs facilitate the translation of technologies. In this regard, BioDAOs can be viewed as collaborative research translation engines and a novel form of biotech organization that develops IP through an online-native approach.</p><figure style="max-width:1600pxpx" class="w-richtext-align-fullwidth w-richtext-figure-type-image"><div><img src="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/641612fa826a425534e2ed72_6412f67c0ab8d6e7a6a14564_Z9JhN1jW7h-cnr6SWrQ8NzpTVvAXTZ5ykNj0J_pcJo6GSIbVeKXuCYznMmyUYblC5ho57fvraYvUVTRjeuC6gI603AaXH9kZRsoAmhTVi211zqGpeo4Tni_XO2ur_nLlu88-1V7mwXdsJV3fCN2jLA.png" alt="" loading="lazy"/></div></figure><h2>How do BioDAOs differ from investment DAOs?</h2><p><a href="https://cointelegraph.com/news/what-are-investment-daos-and-how-do-they-work">Investment DAOs</a>, such as <a href="https://www.metacartel.org/">MetaCartel</a>, <a href="https://flamingodao.xyz/">FlamingoDAO</a>, <a href="https://www.thelao.io/">The LAO</a> and <a href="https://beakerdao.xyz/">BeakerDAO</a>, primarily focus on pooling capital to generate profits that are distributed to their stakeholders. These organizations represent a collective of investors aiming to achieve the highest possible risk-adjusted financial returns. For instance, a member of The LAO may receive a distribution of profits resulting from the capital deployed by The LAO into a project.</p><p>‍</p><p>On the other hand, BioDAOs concentrate on developing novel IP and funding research and development of its members. The capital they deploy aims to generate value for their members and returns that can be reinvested in further R&amp;D, rather than yielding profits for stakeholders or distributing them. Similar to how a university member benefits from enhanced research facilities, program funding, and administrative support provided by the university endowment without receiving direct proceeds, a BioDAO member benefits from the organization&#x27;s successful R&amp;D efforts.</p><p>‍</p><p>BioDAOs are designed to facilitate and support vertically integrated R&amp;D by granting members access to necessary resources and expertise for the successful development and commercialization of new biotechnology products and services. The community isn&#x27;t primarily composed of investors; instead, it consists of researchers, entrepreneurs, companies, patients, and other stakeholder groups, most of whom contribute their time and effort rather than capital.</p><p>‍</p><p>The activities of a BioDAO encompass funding R&amp;D investments and other functions such as community education, company formation, project incubation, access to expertise and knowledge, networking opportunities, member data aggregation, and assistance with regulatory compliance and various challenges. By offering these resources and support, BioDAOs aid their members in overcoming the numerous obstacles involved in transitioning technology from the research and development stage to a commercially viable product or service.</p><figure style="max-width:1600pxpx" class="w-richtext-align-fullwidth w-richtext-figure-type-image"><div><img src="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/641612fababae474acdb9aa5_6412f67ca909036e90a4b203_qbd9eswOXlLQoiVvgEkb1qc9bWznFTQAa06KwDQwrejN5SkFszXypWRMaEwAZhbuWHdnWV_qZZTnuT699V7mRWglcF8_80v4NuVOzvNAVOEzVxFdYl_gqVLsJ6BTwnnAW2Q0liYI8ZIJCN4jnMGtPA.png" alt="" loading="lazy"/></div></figure><h2>The mission of BioDAOs is to incubate and translate research</h2><p>The mission and vision of BioDAOs are patient- and-impact-centric compared to VC funding. While VC funding emphasizes maximizing return on investment for partners or shareholders, BioDAOs concentrate on supporting and facilitating the development of effective biotechnology products and services for humanity. Structured around a sustainability loop, BioDAOs create an endowment to fund research indefinitely. Below is an example of how VitaDAO has structured its sustainability loop.</p><figure style="max-width:1600pxpx" class="w-richtext-align-fullwidth w-richtext-figure-type-image"><div><img src="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/641612fafbe89f979ea66a5c_6412f67d3ef414e8870efc7f_kAtZJMc8lpkI7QOtmiYxhVmmEXVUiqFpp5ry2i2EUOiiuioXb6PWJv64xDNKa3GPU3_Y4Y_6kv9EN5xTdOgEMfkYdJ881IRVOCAPiZ68Gi8dyDt9HjYjaYKxhvclMI4fdzvbv0438yergolL8Omiog.png" alt="" loading="lazy"/></div></figure><p>BioDAOs generally offer resources and support to their members, helping them develop and commercialize new biotechnology products and services. This assistance can include funding for research and development, access to expertise and knowledge, and networking opportunities within the BioDAO community. In contrast to VC firms, which exclusively focus on investing in companies to generate financial returns for their investors, BioDAOs are solely dedicated to funding R&amp;D that benefits their communities within their respective subject areas.</p><p>As a result, the mission and vision of BioDAOs align more closely with the needs and objectives of researchers and patients.</p><h2>Examples of BioDAOs and Their Activities<strong> </strong></h2><p><a href="https://www.vitadao.com/">VitaDAO</a>, among the first BioDAOs, exemplifies how a BioDAO&#x27;s function fundamentally differs from an investment DAO. VitaDAO comprises working groups of experts in various fields (refer to the figure above). Anyone can join VitaDAO by contributing either funding or time (work). In return, they receive governance tokens in the organization, granting them voting rights on proposals, such as which research projects to fund or how to support a project. The fact that many VitaDAO members join by contributing time and receive tokens, rather than providing funding, significantly differentiates it from an investment DAO. VitaDAO features many more operational roles than funding roles. Many of the largest token holders are those who actively participate in research project sourcing, evaluation, peer review, and operational activities for the DAO. Another major differentiator from an investment DAO lies in the allocation of proceeds from funding research that generates and monetizes IP. In VitaDAO, these proceeds return to the VitaDAO treasury to finance further projects. In an investment DAO, a portion of the proceeds directly goes to its members, but in VitaDAO, no portion is directly distributed to VITA holders. Instead, similar to a university researcher who may benefit from better facilities and increased research funding due to successful investments made by the university endowment, a VitaDAO member may gain advantages from the organization&#x27;s funding activities.</p><p>‍</p><p>VitaDAO community members with relevant experience collaborate with researchers on their projects, reviewing data and offering feedback on experimental direction. For instance, VitaDAO&#x27;s deal flow and legal working groups negotiate deal terms with universities on behalf of the researcher and the DAO. The DAO efficiently leverages its extensive network of highly effective individuals using token incentivization. As research progresses, DAO community members assist with the creation of spin-outs to advance research to the next stage.</p><p>‍</p><p>This interdisciplinary, cross working group approach to incubating and advancing research sets BioDAOs apart. In some cases, the DAO is so proficient in this task that negotiating research agreements and initiating projects takes <a href="https://from.ncl.ac.uk/funding-science-through-blockchain-technology-and-cryptocurrencies">weeks</a>, compared to the industry standard of <a href="https://from.ncl.ac.uk/funding-science-through-blockchain-technology-and-cryptocurrencies">months</a>. Some BioDAO activities, such as <a href="https://vitadao.medium.com/decentralized-technology-transfer-dtt-1f12a90aa641">decentralized tech transfer (DTT)</a>, capitalize on the community and academic consultants as a collective intelligence to design experiments, create research projects, and generate IP within the DAO itself.</p><h2>Decentralize or not? That is the question.</h2><p>Biopharma R&amp;D is gravitating toward increased decentralization, outsourcing much high-risk work to specialist contract organizations while keeping IP and data storage centralized internally. BioDAOs, however, offer an alternative by federating IP and data on Ethereum instead of keeping them siloed. This creates a more efficient superstructure and a new paradigm for biopharma R&amp;D, boasting benefits like standardized data generation and decentralized analysis and interpretation.</p><p>Data structure and quality can vary significantly when performed by disparate entities, giving federated data acquisition an advantage over siloed, unconnected systems. Federated data is more likely to generate valuable insights through superior statistical power because it is compared against similar data in an open, connected system. For instance, RNA sequencing is highly sensitive to <a href="https://academic.oup.com/nargab/article/2/3/lqaa078/5909519">batch effects</a>, and using a single high-quality RNAseq provider to federate data is more likely to result in the highest statistical power than multiple providers who don&#x27;t share data and correct each dataset for data science purposes.</p><p>‍</p><p>Data federation has compelling benefits, especially in areas like clinical trial recruitment. If clinical trial repositories or patient data are not connected via data federation, both the biopharma company and the patient or physician may miss eligible patients for clinical trials. Just as efficient financial markets require maximum liquidity on both supply and demand sides, data also needs to be highly liquid to create the most value for patients and biopharma companies.</p><p>However, centralization has its advantages in specific scenarios. For example, therapeutics manufacturing can benefit from centralization through economies of scale, resulting in the best drug prices for patients. Moreover, centralized data capture and/or storage can lead to dataset standardization. When federated, this standardized data—originally captured and stored centrally—can be even more advantageous to biopharma R&amp;D, bringing top scientific and medical minds to the data for high-value decision-making. Existing biopharma companies often capture these centralization benefits, but there are numerous advantages of decentralization that are not fully exploited.</p><p>‍</p><p>Although biopharma is moving toward more significant decentralization, it&#x27;s only tapping into a fraction of the potential benefits. Most pharmaceutical companies have venture investment arms, but the quality and quantity of deal flow are constrained by the limited size of corporate venture teams. By expanding the team size and opening it up to a community, it&#x27;s likely to increase connections, deal flow quality and quantity, and the expertise leveraged for decision-making. Decentralized entities also have competitive advantages, such as greater access to capital and patients. Decentralization offers a genuine means to regain <a href="https://www2.deloitte.com/us/en/insights/industry/life-sciences/trust-in-biopharmaceutical-companies-covid.html">public trust lost in recent years</a>. This can be achieved by providing incentives and governance rights to patients participating in clinical research, shifting biopharma&#x27;s focus from profits to patient value. Compensating patients with ownership and governance rights in the medicines they often risk their lives for can significantly increase their willingness to participate in research and expedite the clinical research process. For example, <a href="https://www.statnews.com/2020/10/28/recruitment-retention-silent-crises-clinical-trials/">clinical trial recruitment often limits the progression of clinical-stage therapeutics</a>, and the lack of a sense of ownership and governance among participating patients may be partially responsible. This shift from profit to patient value could boost biopharma&#x27;s public trust and efficiency. In this respect, BioDAOs offer a solution that prioritizes patients over shareholders as the primary stakeholders.</p><h2>Conclusion and future outlook for BioDAOs</h2><p>BioDAOs represent a distinctive type of DAO that focuses on creating a comprehensive research translation ecosystem and novel IP creation engines. This approach enables BioDAOs to connect scientific innovation with real-world application, making them valuable players in the fast-paced biotechnology sector.</p><p>‍</p><p>In the future, one might imagine that BioDAOs natively integrate AI and LLM capabilities, built and steered by their members to outright produce novel IP and therapeutics themselves and coordinate their development, thus decoupling from the current university and industry funding landscape. We believe that the pace and speed at which this may happen could surprise industry and provide an extremely valuable addition to the research landscape, given the agility, speed and open source nature that is required to make AI drug development capabilities and model development successful.</p><p>‍</p><p>Unlike investment DAOs, BioDAOs generate returns to finance R&amp;D rather than distribute profits to stakeholders. Nevertheless, similar to how university researchers and students benefit from improved research facilities and program funding provided by university endowments, BioDAO members may also reap the rewards of the BioDAOs&#x27; successes.</p><p>‍</p><p>The existence of BioDAOs is grounded in the idea that patients and researchers are disenfranchised from the core stages of therapeutic development. Yet, they they have the strongest incentive and motivation for finding cures. Community-governed research translation organizations offer a solution. The motivations for prestige among academics and profits among venture capitalists are potent, but the desire for patients to alleviate their suffering is even more powerful. This underutilized driving force from patients could accelerate drug discovery, and BioDAOs aim to harness that potential.</p><p>‍</p><p>In the future, BioDAOs are poised to play a vital role in advancing biotechnology, biotech-centric AI and bringing novel innovations to market. As DAO technology continues to evolve, BioDAOs are expected to gain wider adoption. The enormous potential of BioDAOs to drive progress and foster collaboration in biotechnology is disruptive and worth monitoring in the years to come.<br/>‍<br/>To learn more about BioDAOs, check out our the <a href="https://docs.molecule.to/bio.xyz/biodao-bible/introduction">BioDAO Bible</a> and join the conversation or send us your questions or feedback on <a href="https://discord.gg/6ZeDSjhM2g">our Discord</a>!</p></div><div class="spacer-large"></div><div class="blog-tags-and-share btm"><div class="blog-social-links"><div class="filter blog-inner">Share This</div><div class="social-hidden"><a href="#" class="_w-inline-block blog-social-link twitter w-inline-block"><img src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6323026f92a78e460ba0ad45_twitter.svg" loading="lazy" alt="" class="blog-social-img"/></a><a href="#" class="_w-inline-block blog-social-link facebook w-inline-block"><img src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6348101770281e9027754b63_fb-green.svg" loading="lazy" alt="" class="blog-social-img"/></a><a href="#" class="_w-inline-block blog-social-link linked w-inline-block"><img src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6323026fa0941a747b45eaf9_linkedin.svg" loading="lazy" alt="" class="blog-social-img"/></a></div><div class="html-embed w-embed"><a class="w-inline-block blog-social-link twitter" href="https://twitter.com/intent/tweet?" target="_blank" title="Tweet" onclick="window.open('https://twitter.com/intent/tweet?text=%20Check%20up%20this%20awesome%20content' + encodeURIComponent(document.title) + ':%20 ' + encodeURIComponent(document.URL)); return false;"><img alt=“twitter-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/668fcd45359aba9eb2704a86_664735ffce358da0095d6142_x.svg" width=16" height=auto" ></a></div><div class="html-embed w-embed"><a class="w-inline-block blog-social-link facebook" href="https://www.facebook.com/sharer/sharer.php?u=&t=" title="Share on Facebook" target="_blank" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=' + encodeURIComponent(document.URL) + '&t=' + encodeURIComponent(document.URL)); return false;"><img alt=“facebook-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6348101770281e9027754b63_fb-green.svg" width=16" height=auto" margin-left=12px"></a></div><div class="code-embed-2 w-embed"><a class="w-inline-block blog-social-link linked" href="http://www.linkedin.com/shareArticle?mini=true&url=&title=&summary=&source=" target="_blank" title="Share on LinkedIn" onclick="window.open('http://www.linkedin.com/shareArticle?mini=true&url=' + encodeURIComponent(document.URL) + '&title=' + encodeURIComponent(document.title)); return false;"><img alt="linkedin-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/6323026fa0941a747b45eaf9_linkedin.svg" width="16" height=auto"></a></div><div class="w-embed w-script"><style><a class="w-inline-block blog-social-link twitter" href="https://twitter.com/intent/tweet?" target="_blank" title="Tweet" onclick="window.open('https://twitter.com/intent/tweet?text=%20Check%20up%20this%20awesome%20content' + encodeURIComponent(document.title) + ':%20 ' + encodeURIComponent(document.URL)); return false;"><img alt=“twitter-icon" src="https://cdn.prod.website-files.com/5fcf058ca5a742c36f247ef0/624599b9beac3569237f4d45_twitter-blog.svg" width=16" height=auto"></a>



<a class="w-inline-block blog-social-link fb" href="https://www.facebook.com/sharer/sharer.php?u=&t=" title="Share on Facebook" target="_blank" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=' + encodeURIComponent(document.URL) + '&t=' + encodeURIComponent(document.URL)); return false;"><img alt=“facebook-icon" src="https://cdn.prod.website-files.com/5fcf058ca5a742c36f247ef0/624599b9c3e7fb0b56a00b6d_fb-blog.svg" width=16" height=auto"> </a>



<a class="w-inline-block blog-social-link linked" href="http://www.linkedin.com/shareArticle?mini=true&url=&title=&summary=&source=" target="_blank" title="Share on LinkedIn" onclick="window.open('http://www.linkedin.com/shareArticle?mini=true&url=' + encodeURIComponent(document.URL) + '&title=' + encodeURIComponent(document.title)); return false;"><img alt=“linkedin-icon" src="https://cdn.prod.website-files.com/5fcf058ca5a742c36f247ef0/624599b9878fd25a93c4342c_linkedin-blog.svg" width=16" height=auto"></a>

</style>




<!DOCTYPE html>
<html>
<body>
<style>
button{
background-color:#ffffff;
</style>
<button  onclick="copyToClipboard()" style="background-color:#ffffff;" ><img alt=“link-icon" src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/63481017df196e8327d2ffa8_link-green.svg" width=16" height=auto"></button>

<script>
function copyToClipboard(text) {
var inputc = document.body.appendChild(document.createElement("input"));
inputc.value = window.location.href;
inputc.focus();
inputc.select();
document.execCommand('copy');
inputc.parentNode.removeChild(inputc);
alert("URL Copied.");
}
</script>

</body>
</html></div></div></div><div class="spacer-xlarge"></div></div><div class="container-large"><div class="line"></div><div class="spacer-medium"></div><h3 class="heading-style-h4">More from the BIO ecosystem</h3><div class="blog-grid-wrapper inner w-dyn-list"><div role="list" class="blog-list-grid w-dyn-items"><div role="listitem" class="blog-grid-item w-dyn-item"><a href="/blog-posts/binance-labs-invests-in-bio-protocol-to-accelerate-decentralized-science-desci-funding" class="blog-grid-link-block w-inline-block"><div><div class="blog-grid-img-cont"><img src="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/672e4f59ab2df01f7d1c3284_bpart2.jpeg" loading="lazy" alt="" sizes="(max-width: 479px) 94vw, (max-width: 991px) 44vw, (max-width: 1279px) 28vw, (max-width: 1919px) 29vw, 440px" srcset="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/672e4f59ab2df01f7d1c3284_bpart2-p-500.jpeg 500w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/672e4f59ab2df01f7d1c3284_bpart2-p-800.jpeg 800w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/672e4f59ab2df01f7d1c3284_bpart2-p-1080.jpeg 1080w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/672e4f59ab2df01f7d1c3284_bpart2.jpeg 1200w" class="blog-grid-img"/><div class="green-overlay dark"></div></div><h5 class="h5 article-grid-name">Binance Labs Invests in BIO Protocol to Accelerate Decentralized Science (DeSci) Funding</h5><p class="paragraph blog-synopsis">Binance Labs has invested in BIO Protocol, a pioneering protocol transforming the way early-stage scientific research is financed and commercialized using blockchain technology. </p></div><div class="blog-grid-read-more-left"><div class="blog-read-more dark">Read More</div></div></a></div><div role="listitem" class="blog-grid-item w-dyn-item"><a href="/blog-posts/desci-2-0-how-bio-will-unleash-biotech-revolution" class="blog-grid-link-block w-inline-block"><div><div class="blog-grid-img-cont"><img src="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/6736fee30cf9e95da3a04e48_Copy%20of%20Blog%20Header%20-%20Announcing%20Genesis-min.jpg" loading="lazy" alt="" sizes="(max-width: 479px) 94vw, (max-width: 991px) 44vw, (max-width: 1279px) 28vw, (max-width: 1919px) 29vw, 440px" srcset="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/6736fee30cf9e95da3a04e48_Copy%20of%20Blog%20Header%20-%20Announcing%20Genesis-min-p-500.jpg 500w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/6736fee30cf9e95da3a04e48_Copy%20of%20Blog%20Header%20-%20Announcing%20Genesis-min-p-800.jpg 800w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/6736fee30cf9e95da3a04e48_Copy%20of%20Blog%20Header%20-%20Announcing%20Genesis-min-p-1080.jpg 1080w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/6736fee30cf9e95da3a04e48_Copy%20of%20Blog%20Header%20-%20Announcing%20Genesis-min-p-1600.jpg 1600w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/6736fee30cf9e95da3a04e48_Copy%20of%20Blog%20Header%20-%20Announcing%20Genesis-min.jpg 1920w" class="blog-grid-img"/><div class="green-overlay dark"></div></div><h5 class="h5 article-grid-name">DeSci 2.0: How BIO Will Unleash a Biotech Revolution</h5><p class="paragraph blog-synopsis">What if we could funnel memecoin liquidity into funding science? Crypto would be regarded in a completely different light by the public.</p></div><div class="blog-grid-read-more-left"><div class="blog-read-more dark">Read More</div></div></a></div><div role="listitem" class="blog-grid-item w-dyn-item"><a href="/blog-posts/bio-incubator-cohort-2-early-admissions-long-covid-labs-quantum-biology-dao-curetopia" class="blog-grid-link-block w-inline-block"><div><div class="blog-grid-img-cont"><img src="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/67110ddfed8723d901754b96_C2_Announcement.jpg" loading="lazy" alt="" sizes="(max-width: 479px) 94vw, (max-width: 991px) 44vw, (max-width: 1279px) 28vw, (max-width: 1919px) 29vw, 440px" srcset="https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/67110ddfed8723d901754b96_C2_Announcement-p-500.jpg 500w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/67110ddfed8723d901754b96_C2_Announcement-p-800.jpg 800w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/67110ddfed8723d901754b96_C2_Announcement-p-1080.jpg 1080w, https://cdn.prod.website-files.com/63242cd26370073e61c4b5c6/67110ddfed8723d901754b96_C2_Announcement.jpg 1547w" class="blog-grid-img"/><div class="green-overlay dark"></div></div><h5 class="h5 article-grid-name">BIO Incubator Cohort 2 Early Admissions: Long COVID Labs, Quantum Biology DAO &amp; Curetopia</h5><p class="paragraph blog-synopsis">After the success of the first generation of BioDAOs incubated by BIO and our ongoing Genesis launch still underway, we are proud to unveil the first BioDAOs admitted into Cohort 2.</p></div><div class="blog-grid-read-more-left"><div class="blog-read-more dark">Read More</div></div></a></div></div></div></div></div><div class="section-new footer"><div class="global-container-footer"><div class="w-layout-grid grid"><div id="w-node-b808921b-8b91-4c4c-47b1-aad715324256-15324252" class="footer_logo-container"><a href="/" class="footer-logo-link w-inline-block"><div class="w-embed"><svg width="140" height="40" viewBox="0 0 140 40" fill="currentColor" xmlns="http://www.w3.org/2000/svg">
<path fill-rule="evenodd" clip-rule="evenodd" d="M63.8372 0H121.429C131.165 0 139.059 7.89169 139.059 17.6281V22.3701C139.059 32.1044 131.165 39.9981 121.429 39.9981H63.8372C54.1029 39.9981 46.2092 32.1064 46.2092 22.3701V17.6281C46.2092 7.89375 54.1009 0 63.8372 0ZM63.431 33.5387H75.3649L75.367 33.5366C79.7089 33.5366 83.4557 30.1571 83.5583 25.8152C83.6034 23.8803 82.9529 22.0992 81.8387 20.7039C81.2909 20.0165 81.2457 19.0644 81.6787 18.299C82.4584 16.9202 82.838 15.2868 82.6534 13.5509C82.2204 9.49014 78.607 6.50665 74.5236 6.50665H63.431C57.4845 6.50665 52.6666 11.3266 52.6666 17.271V22.7743C52.6666 28.7187 57.4865 33.5387 63.431 33.5387ZM92.6339 33.4894C94.0764 33.4894 95.246 32.3198 95.246 30.8773V9.0736C95.246 7.6311 94.0785 6.4615 92.6339 6.4615C91.1893 6.4615 90.0198 7.6311 90.0198 9.0736V30.8773C90.0198 32.3198 91.1914 33.4894 92.6339 33.4894ZM120.963 33.5387C127.387 33.5387 132.597 28.3309 132.597 21.9043V18.1431C132.597 11.7185 127.389 6.5087 120.963 6.5087H113.342C106.917 6.5087 101.708 11.7165 101.708 18.1431V21.9043C101.708 28.3288 106.915 33.5387 113.342 33.5387H120.963ZM1.32133 38.693C0.863753 38.2149 0.512874 37.6486 0.287163 37.0269C0.0614513 36.4051 -0.0329371 35.7444 0.0101533 35.0858C0.0532436 34.4271 0.233813 33.7828 0.539549 33.198C0.845285 32.6111 1.26798 32.0961 1.78301 31.6837C3.00956 30.7983 3.98234 30.5973 4.99694 30.3876C5.2333 30.3388 5.47192 30.2894 5.71655 30.2309C7.91621 29.6995 9.80808 28.0394 9.46541 25.6059C9.169 23.5095 7.65363 22.9593 6.28168 22.4612C5.0418 22.011 3.91906 21.6034 3.91906 20.1354C3.91906 18.6668 5.04105 18.2595 6.28058 17.8095C7.65088 17.312 9.16482 16.7624 9.46541 14.6691C9.80808 12.254 7.91621 10.5899 5.71655 10.0441C5.47499 9.98628 5.2393 9.93733 5.00589 9.88886C3.98819 9.67751 3.0139 9.47518 1.78712 8.58722C1.27209 8.17479 0.847337 7.6577 0.541601 7.0729C0.235865 6.484 0.0552955 5.84175 0.0122052 5.18103C-0.0308852 4.52236 0.0635032 3.85959 0.289215 3.23786C0.514926 2.61613 0.867857 2.0498 1.32544 1.5717C1.80353 1.11412 2.36986 0.761189 2.98954 0.535477C3.60922 0.309766 4.27199 0.215377 4.93066 0.258468C5.58933 0.301558 6.23158 0.482127 6.81843 0.787864C7.40323 1.0936 7.92031 1.51835 8.33275 2.03338C9.2203 3.26294 9.42284 4.23884 9.63409 5.25666C9.68266 5.49068 9.73169 5.72692 9.78961 5.96897C10.3211 8.17068 11.9811 10.0626 14.4126 9.71988C16.5056 9.42349 17.0555 7.90713 17.5533 6.53417C18.0033 5.29323 18.4108 4.16943 19.8769 4.16943C21.3428 4.16943 21.7503 5.2916 22.2007 6.53158C22.6991 7.90377 23.2498 9.42023 25.3452 9.71988C27.7583 10.0626 29.4183 8.17068 29.9682 5.96897C30.0269 5.72361 30.0764 5.48423 30.1253 5.24707C30.3348 4.23271 30.5358 3.25908 31.4189 2.03338C31.8314 1.51835 32.3484 1.0936 32.9332 0.787864C33.518 0.482127 34.1623 0.301558 34.821 0.258468C35.4797 0.215377 36.1404 0.309766 36.7621 0.535477C37.3818 0.761189 37.9502 1.11412 38.4262 1.5717C38.8838 2.04774 39.2367 2.61613 39.4625 3.23786C39.6882 3.85959 39.7825 4.52031 39.7395 5.18103C39.6964 5.8397 39.5158 6.484 39.2101 7.07085C38.9043 7.6577 38.4796 8.17273 37.9646 8.58517C36.7355 9.47236 35.7612 9.6751 34.7466 9.88625C34.5128 9.9349 34.2768 9.98401 34.0351 10.042C31.8293 10.5694 29.9395 12.2335 30.2822 14.6671C30.5784 16.7605 32.0927 17.3095 33.4643 17.8067C34.7048 18.2564 35.8285 18.6638 35.8285 20.1334C35.8285 21.6027 34.7061 22.0102 33.4663 22.4603C32.0952 22.9581 30.5806 23.5079 30.2822 25.6038C29.9395 28.0189 31.8314 29.6789 34.0351 30.2063C34.2834 30.2668 34.5258 30.3175 34.7661 30.3678C35.7729 30.5786 36.7437 30.7819 37.9646 31.6631C38.4796 32.0756 38.9043 32.5927 39.2101 33.1775C39.5158 33.7643 39.6964 34.4066 39.7395 35.0673C39.7825 35.7259 39.6882 36.3887 39.4625 37.0105C39.2367 37.6322 38.8838 38.1985 38.4262 38.6766C37.9502 39.1342 37.3818 39.4871 36.7621 39.7128C36.1404 39.9385 35.4797 40.0329 34.821 39.9898C34.1623 39.9468 33.518 39.7662 32.9332 39.4605C32.3484 39.1547 31.8314 38.73 31.4189 38.2129C30.535 36.9883 30.3345 36.0154 30.1257 35.0021C30.0767 34.764 30.0272 34.5236 29.9682 34.2773C29.4368 32.0756 27.7768 30.1837 25.3452 30.5264C23.2501 30.8228 22.7004 32.339 22.2025 33.7119C21.7525 34.9529 21.345 36.0768 19.8769 36.0768C18.4081 36.0768 18.0008 34.9533 17.551 33.7124C17.0539 32.3408 16.5047 30.8259 14.4126 30.5264C11.9995 30.1837 10.3395 32.0756 9.78961 34.2814C9.73151 34.5234 9.68236 34.7597 9.63365 34.9939C9.42256 36.0088 9.21968 36.9842 8.33275 38.2129C7.92031 38.73 7.40528 39.1547 6.81843 39.4605C6.23363 39.7662 5.58933 39.9468 4.93066 39.9898C4.27199 40.0329 3.61128 39.9385 2.98954 39.7128C2.36781 39.4871 1.80148 39.1342 1.32544 38.6766L1.32133 38.693ZM75.525 22.331H74.7924H74.7883H59.6267C58.7054 22.331 57.9585 23.0779 57.9585 23.9992C57.9585 26.72 60.1643 28.9259 62.8851 28.9259H75.6501C77.6836 28.9259 79.2882 27.0832 78.884 24.9759C78.5844 23.4103 77.1214 22.331 75.527 22.331H75.525ZM74.7883 17.7162H59.6246V17.7182C58.7033 17.7182 57.9564 16.9713 57.9564 16.05C57.9564 13.3292 60.1622 11.1234 62.883 11.1234H74.6016C76.3867 11.1234 77.9852 12.4592 78.0796 14.2423C78.1801 16.1424 76.6679 17.7162 74.7883 17.7162ZM121.837 11.1234H112.464C109.443 11.1234 106.995 13.5716 106.995 16.5917V23.4575C106.995 26.4776 109.443 28.9258 112.464 28.9258H121.837C124.857 28.9258 127.305 26.4776 127.305 23.4575V16.5917C127.305 13.5716 124.857 11.1234 121.837 11.1234Z" fill="currentColor"/>
</svg></div></a></div><div id="w-node-b808921b-8b91-4c4c-47b1-aad71532425c-15324252" class="footer-link-col"><a href="#" class="footer-link hide">BIO Token</a><a href="/blog" target="_blank" class="footer-link">Blog</a><a href="/scientists" target="_blank" class="footer-link">Scientists</a><a href="https://commonwealth.im/bio-protocol" target="_blank" class="footer-link">Governance</a><a href="https://commonwealth.im/bio-protocol" target="_blank" class="footer-link">Governance Forum</a><a href="https://docs.bio.xyz/bio" target="_blank" class="footer-link">Docs</a><a href="https://dune.com/kiba/bioconomy" target="_blank" class="footer-link">Ecosystem Analytics</a></div><div id="w-node-b808921b-8b91-4c4c-47b1-aad715324265-15324252" class="footer-link-col"><a href="/bio-token" target="_blank" class="footer-link">BIO Token</a><a href="http://claim.bio.xyz" target="_blank" class="footer-link">BIO Airdrop</a><a href="https://app.bio.xyz/genesis" target="_blank" class="footer-link">BIO Genesis Event</a></div><div id="w-node-bb7a4f97-40f0-da97-0465-382a61748308-15324252" class="footer-link-col legal"><a href="/terms-of-use" target="_blank" class="footer-link">Terms of Use</a><a href="https://docs.bio.xyz/bio/media-kit/bio-logos" target="_blank" class="footer-link">Media Kit</a><a href="/terms-of-use" target="_blank" class="footer-link hide">Contact Us</a><div fs-cc="manager" class="fs-cc-manager_component"><div fs-cc="open-preferences" class="fs-cc-manager_button"><div class="footer-link">Cookie preferences</div></div><div fs-cc="interaction" class="fs-cc-manager_trigger"></div></div></div><div id="w-node-b808921b-8b91-4c4c-47b1-aad71532426a-15324252" class="footer_socials-container"><div class="footer-socials"><a href="http://t.me/bio_protocol" target="_blank" class="footer-social-link w-inline-block"><div class="icon-embed-xsmall w-embed"><?xml version="1.0" encoding="UTF-8"?><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 43.97 40"><path d="M43.14.55c-.75-.64-1.93-.73-3.15-.24h0C38.71.83,3.73,15.83,2.3,16.44c-.26.09-2.52.93-2.29,2.81.21,1.69,2.03,2.4,2.25,2.48l8.89,3.05c.59,1.96,2.76,9.21,3.25,10.76.3.97.79,2.23,1.65,2.49.75.29,1.5.03,1.98-.35l5.44-5.04,8.78,6.85.21.12c.6.26,1.17.4,1.71.4.42,0,.83-.08,1.21-.24,1.31-.54,1.84-1.79,1.9-1.94L43.83,3.75c.4-1.82-.16-2.75-.69-3.2ZM19,26l-3,8-3-10L36,7l-17,19Z" fill="currentColor"/></svg></div></a><a href="https://x.com/bioprotocol" target="_blank" class="footer-social-link w-inline-block"><div class="icon-embed-xsmall w-embed"><svg width="24" height="22" viewBox="0 0 24 22" fill="none" xmlns="http://www.w3.org/2000/svg">
<path d="M18.9573 0.0908203H22.6399L14.5632 9.54961L24 22.3765H16.5928L10.7969 14.5749L4.16391 22.3765H0.481255L9.03923 12.2613L0 0.0908203H7.585L12.8265 7.2145L18.9573 0.0908203ZM17.6704 20.1598H19.7106L6.51787 2.23223H4.3313L17.6809 20.1598H17.6704Z" fill="currentColor"/>
</svg></div></a><a href="http://discord.gg/YnwhX6GzWH" target="_blank" class="footer-social-link w-inline-block"><div class="icon-embed-small w-embed"><?xml version="1.0" encoding="UTF-8"?><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 36 26"><path class="cls-1" d="M31.07,3.25S27.33.34,22.89,0l-.39.79c4,.97,5.84,2.37,7.76,4.08-3.31-1.68-6.58-3.25-12.27-3.25s-8.97,1.58-12.27,3.25c1.92-1.71,4.11-3.26,7.76-4.08l-.39-.79C8.44.44,4.91,3.25,4.91,3.25c0,0-4.19,6.03-4.91,17.88,4.22,4.84,10.63,4.87,10.63,4.87l1.34-1.78c-2.27-.78-4.85-2.19-7.07-4.73,2.64,1.99,6.65,4.07,13.09,4.07s10.44-2.07,13.09-4.07c-2.22,2.54-4.79,3.94-7.06,4.73l1.34,1.78s6.41-.03,10.63-4.87c-.74-11.84-4.93-17.88-4.93-17.88ZM12.66,17.88c-1.59,0-2.87-1.45-2.87-3.25s1.28-3.25,2.87-3.25,2.87,1.45,2.87,3.25-1.28,3.25-2.87,3.25ZM23.3,17.88c-1.59,0-2.87-1.45-2.87-3.25s1.28-3.25,2.87-3.25,2.87,1.45,2.87,3.25-1.29,3.25-2.87,3.25Z" fill="currentColor"/>
</svg></div></a><a href="https://warpcast.com/bioxyz" target="_blank" class="footer-social-link w-inline-block"><div class="icon-embed-xsmall w-embed"><svg width="24" height="23" viewBox="0 0 24 23" fill="none" xmlns="http://www.w3.org/2000/svg">
<path d="M23.1478 20.5376H23.006V19.6854C23.006 19.2934 22.688 18.9755 22.296 18.9755V6.33624H23.0769L24 3.21191H19.5976V0.0878906H4.11838V3.21223H0L0.923114 6.33656H1.70404V18.9758C1.31198 18.9758 0.994049 19.2937 0.994049 19.6858V20.5379H0.852179C0.460119 20.5379 0.14219 20.8559 0.14219 21.2479V22.1001H8.0949V21.2479C8.0949 20.8559 7.77697 20.5379 7.38491 20.5379H7.24304V19.6858C7.24304 19.2937 6.92511 18.9758 6.53305 18.9758H6.39118V12.0171H6.41355C6.6647 9.23052 9.00683 7.04655 11.8586 7.04655C14.7104 7.04655 17.0525 9.2302 17.3037 12.0171H17.326V18.9898C17.002 19.0557 16.7579 19.3423 16.7579 19.6858V20.5379H16.616C16.224 20.5379 15.9061 20.8559 15.9061 21.2479V22.1001H23.8588V21.2479C23.8588 20.8559 23.5408 20.5379 23.1488 20.5379L23.1478 20.5376Z" fill="currentColor"/>
</svg></div></a><a href="https://www.youtube.com/@bio_acc" target="_blank" class="footer-social-link w-inline-block"><div class="icon-embed-xsmall w-embed"><svg width="28" height="22" viewBox="0 0 28 22" fill="none" xmlns="http://www.w3.org/2000/svg">
<g clip-path="url(#clip0_255_2578)">
<path d="M27.7361 4.62909C27.7361 4.62909 27.4777 2.52909 26.5973 1.65679C25.5473 0.429095 24.3196 0.429095 23.7946 0.429095C19.8531 0.0817871 13.9973 0.0817871 13.9973 0.0817871C13.9973 0.0817871 8.13346 0.0817871 4.2 0.340249C3.675 0.429095 2.44731 0.429095 1.39731 1.56794C0.525 2.44833 0.266538 4.54833 0.266538 4.54833C0.266538 4.54833 0 6.99563 0 9.45102V11.7287C0 14.176 0.266538 16.5426 0.266538 16.5426C0.266538 16.5426 0.533077 18.6426 1.40538 19.5149C2.45538 20.7426 3.85269 20.6537 4.46654 20.8233C6.74423 21.001 14.0054 21.0818 14.0054 21.0818C14.0054 21.0818 19.8692 21.0818 23.8027 20.7345C24.3277 20.6456 25.5554 20.6456 26.6054 19.5068C27.4777 18.6345 27.7442 16.5345 27.7442 16.5345C27.7442 16.5345 28.0108 14.0872 28.0108 11.7206V9.44294C28.0108 6.99563 27.7442 4.62909 27.7442 4.62909H27.7361ZM10.5 15.8318V5.33179L19.2473 10.5818L10.5 15.8318Z" fill="currentColor"/>
</g>
<defs>
<clipPath id="clip0_255_2578">
<rect width="28.0027" height="21" fill="currentColor" transform="translate(0 0.0817871)"/>
</clipPath>
</defs>
</svg></div></a></div></div></div></div></div></div></div><script src="https://d3e54v103j8qbb.cloudfront.net/js/jquery-3.5.1.min.dc5e7f18c8.js?site=62873e140841d3b072b63035" type="text/javascript" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script><script src="https://cdn.prod.website-files.com/62873e140841d3b072b63035/js/webflow.2c35f466abf9ed9edce2d8da317919fb.js" type="text/javascript"></script>
<!-- overflow hidden on body while mobile nav open -->

<script>
document.addEventListener('DOMContentLoaded', () => {
 document.querySelectorAll('.menu-btn-2').forEach(trigger => {
  trigger.addEventListener('click', function(){ 
    this.x = ((this.x || 0) + 1)%2; 
    if(this.x){ 
      document.querySelectorAll('.body').forEach(target => target.classList.add('no-scroll'));
      }
      else{ 
      document.querySelectorAll('.body').forEach(target => target.classList.remove('no-scroll'));
      } 
    });
 });

 document.querySelectorAll('.nav-link-new').forEach(trigger => {
  trigger.addEventListener('click', function(){ 
    document.querySelectorAll('.body').forEach(target => target.classList.remove('no-scroll')); 
    });
 });
});
</script>

<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PL3G78C"
height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->

<!-- GSAP scroll and Fade START -->

<script src="https://cdn.jsdelivr.net/npm/gsap@3.12.5/dist/gsap.min.js"></script>

<script src="https://cdn.jsdelivr.net/npm/gsap@3.12.5/dist/ScrollTrigger.min.js"></script>

<script>
window.Webflow ||= [];
window.Webflow.push(() => {
  gsap.registerPlugin(ScrollTrigger);
  
});


///////////////////// FADE IN ANIMATION ////////////////

  const fadeInElements = gsap.utils.toArray("[fade-in]");

  fadeInElements.forEach((fadeInElement) => {
    gsap.fromTo(
      fadeInElement,
      { opacity: 0, y: 20 }, // Initial state
      {
        // Final state
        opacity: 1,
        y: 0,
        duration: 0.5,
        scrollTrigger: {
          trigger: fadeInElement,
          start: "top 75%", // When top of element reaches 60% in the viewport
          end: "bottom 20%", // When bottom of element reaches 50% in the viewport
          //markers: "true", // Turn markers on (uncomment) to see where the element will start the animation. Be sure to turn off when publishing to the production domain or they will show on the live website. 
        },
      }
    );
  });

  ///////////////////// END FADE IN ANIMATION ////////////////

 ///////////////////// BEGIN FADE LIST ANIMATION ////////////////

  const fadeInLists = gsap.utils.toArray("[fade-list]");

  fadeInLists.forEach((fadeInList) => {
    gsap.fromTo(
      fadeInList.children,
      { opacity: 0, y: 20 }, // Initial state

      {
        // Final state
        opacity: 1,
        y: 0,
        duration: 0.5,
        stagger: 0.2,
        scrollTrigger: {
          trigger: fadeInList,
          start: "top 75%", // When top of element reaches 60% in the viewport
          end: "bottom 20%", // When bottom of element reaches 50% in the viewport
          // markers: "true", // Turn markers on (uncomment) to see where the element will start the animation. Be sure to turn off when publishing to the production domain or they will show on the live website. 
        },
      }
    );
  });

  ///////////////////// END FADE LIST ANIMATION ////////////////
</script>

<!-- GSAP scroll and Fade END -->
</body></html>